mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.006 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.007 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.008 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.008 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |